Read about potential concerns with MAGEC implants related to endcap separation and gaps in biocompatibility testing.

If your email program has trouble displaying this email, view as a webpage. Potential Concerns with MAGEC System Implants - FDA Safety Communication Today, the U.S. Food and Drug Administration (FDA) issued a safety communication to inform patients, their caregivers, and health care providers of mechanical component failures and biocompatibility concerns with NuVasive Specialized Orthopedics MAGEC devices. Read More This safety communication provides: Details about the mechanical component failures and biocompatibility concerns with MAGEC devices. Recommendations for patients and their caregivers. Recommendations for health care providers, including discussions with patients and their caregivers. Actions the FDA is taking to address safety concerns with MAGEC devices. Questions? If you have questions about this FDA Safety Communication, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA